Intervention preparation capable of directionally inducing and increasing quantity of clostridium butyricum in intestines

• Main Authors: LIU FUYAN, MA MING
• Format: Patent
• Language: Chinese; English
• Published: 30.11.2021
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The invention discloses an intervention preparation capable of directionally inducing and increasing quantity of clostridium butyricum in intestines. The intervention preparation comprises components in content proportion of 10%-30% of berberine, 20%-40% of enterococcus faecalis MB508 thallus protein powder and 30%-70% of xylitol. The effect of regulating blood sugar is achieved by inducing and increasing the quantity of clostridium butyricum in intestinal tracts of patients with type 2 diabetes, and the raw materials are safe and reliable and have no toxic or side effects. 本发明公开了一种可定向诱导增加肠内丁酸梭状芽孢杆菌数量的干预制剂，包括包括黄连素、粪肠球菌MB508菌体蛋白粉和木糖醇，其中各组分的含量配比为：黄连素10％-30％，粪肠球菌MB508菌体蛋白粉20％-40％，木糖醇30％-70％。本发明通过诱导增加二型糖尿病患者肠道中丁酸梭状芽孢杆菌的数量达到调节血糖的功效，原料安全可靠无毒副作用。